199 related articles for article (PubMed ID: 19667580)
1. Treatment of postprandial hyperglycemia in type 2 diabetes.
Fasy EA; Buse JB
Postgrad Med; 2001 Dec; 110(6 Suppl):14-9. PubMed ID: 19667580
[TBL] [Abstract][Full Text] [Related]
2. Treating hyperglycemia in type 2 diabetes: new goals and strategies.
Lebovitz HE
Cleve Clin J Med; 2002 Oct; 69(10):809-20. PubMed ID: 12371804
[TBL] [Abstract][Full Text] [Related]
3. Relative contributions of fasting and postprandial glucose increments, glycemic variability, and non-glycemic factors to HbA1c in individuals with type 1 diabetes.
Zhou Y; Zheng M; Deng H; Zheng X; Luo S; Yang D; Mai X; Xu W; Yan J; Weng J
J Diabetes; 2023 Jun; 15(6):465-473. PubMed ID: 37143431
[TBL] [Abstract][Full Text] [Related]
4. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
5. Controlling postprandial hyperglycemia.
Ratner RE
Am J Cardiol; 2001 Sep; 88(6A):26H-31H. PubMed ID: 11576523
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of postprandial endogenous insulin secretion rather than exogenous insulin injection ameliorated insulin antibody-induced unstable diabetes: a case report.
Kaneko K; Satake C; Izumi T; Tanaka M; Yamamoto J; Asai Y; Sawada S; Imai J; Yamada T; Katagiri H
BMC Endocr Disord; 2019 Jan; 19(1):5. PubMed ID: 30621663
[TBL] [Abstract][Full Text] [Related]
7. Postprandial glucose regulation: new data and new implications.
Leiter LA; Ceriello A; Davidson JA; Hanefeld M; Monnier L; Owens DR; Tajima N; Tuomilehto J;
Clin Ther; 2005; 27 Suppl B():S42-56. PubMed ID: 16519037
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of nateglinide in type 2 diabetic patients with modest fasting hyperglycemia.
Saloranta C; Hershon K; Ball M; Dickinson S; Holmes D
J Clin Endocrinol Metab; 2002 Sep; 87(9):4171-6. PubMed ID: 12213867
[TBL] [Abstract][Full Text] [Related]
9. Optimal glycemic control in type 2 diabetes mellitus: fasting and postprandial glucose in context.
Abrahamson MJ
Arch Intern Med; 2004 Mar; 164(5):486-91. PubMed ID: 15006824
[TBL] [Abstract][Full Text] [Related]
10. The genesis and consequences of postprandial hyperglycemia.
Dostou JM; Einhorn D
Postgrad Med; 2001 Dec; 110(6 Suppl):5-13. PubMed ID: 19667579
[TBL] [Abstract][Full Text] [Related]
11. A prospective, randomized, open-label study comparing the efficacy and safety of preprandial and prandial insulin in combination with acarbose in elderly, insulin-requiring patients with type 2 diabetes mellitus.
Yang G; Li C; Gong Y; Li J; Cheng X; Tian H
Diabetes Technol Ther; 2013 Jun; 15(6):513-9. PubMed ID: 23530576
[TBL] [Abstract][Full Text] [Related]
12. FASTING VERSUS POSTPRANDIAL HYPERGLYCEMIA AS A TREATMENT TARGET TO LOWER ELEVATED HEMOGLOBIN A1C.
Shaefer C; Reid T; Vlajnic A; Zhou R; DiGenio A
Endocr Pract; 2015 Dec; 21(12):1323-32. PubMed ID: 26307902
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of preprandial or postprandial Humalog Mix75/25 versus glyburide in patients 60 to 80 years of age with type 2 diabetes mellitus.
Herz M; Sun B; Milicevic Z; Erickson P; Fövènyi J; Grzywa M; Pelikanova T
Clin Ther; 2002 Jan; 24(1):73-86. PubMed ID: 11833837
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of targeting postprandial and fasting hyperglycemia in managing type 2 diabetes mellitus.
Fonseca V
Curr Med Res Opin; 2003; 19(7):635-41. PubMed ID: 14606987
[TBL] [Abstract][Full Text] [Related]
15. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels.
Woerle HJ; Neumann C; Zschau S; Tenner S; Irsigler A; Schirra J; Gerich JE; Göke B
Diabetes Res Clin Pract; 2007 Aug; 77(2):280-5. PubMed ID: 17240473
[TBL] [Abstract][Full Text] [Related]
16. [Current methods of glucose metabolism control in diabetes mellitus].
Scarpitta AM; Sinagra D
Recenti Prog Med; 2003 Jan; 94(1):31-40. PubMed ID: 12632998
[TBL] [Abstract][Full Text] [Related]
17. Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.
Giugliano D; Ceriello A; Razzoli E; Esposito K
Clin Drug Investig; 2008; 28(4):199-210. PubMed ID: 18345710
[TBL] [Abstract][Full Text] [Related]
18. Targeting prandial hyperglycemia: how important is it and how best to do this?
Monnier L; Colette C
Curr Diab Rep; 2008 Oct; 8(5):368-74. PubMed ID: 18778585
[TBL] [Abstract][Full Text] [Related]
19. Comparison of daily glucose excursion by continuous glucose monitoring between type 2 diabetic patients receiving preprandial insulin aspart or postprandial insulin glulisine.
Ohta A; Arai K; Nishine A; Sada Y; Kato H; Fukuda H; Asai S; Nagai Y; Katabami T; Tanaka Y
Endocr J; 2013; 60(2):173-7. PubMed ID: 23047542
[TBL] [Abstract][Full Text] [Related]
20. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
